ChitogenX Inc.
CHGX.CN
Get informed when a big investor buys or sells
+ FollowMarket Cap$627.63K
Close$
Share Statistics
| Market cap | $627,628.00 |
|---|---|
| Enterprise Value | $4.81 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.02 |
| Beta | -2.09 |
| Outstanding Shares | 83,129,520 |
Return
| Return on Equity | 21.10% |
|---|---|
| Return on Assets | -403.64% |
| Return on Invested Capital | 17.24% |
Valuation & Multiples
| P/E Ratio | -0.23 |
|---|---|
| PEG | 1.03 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -3.85 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.88 |
| Debt to Equity | -0.57 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 28, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About ChitogenX Inc.
5 employees
CEO: Pierre Laurin ChitogenX Inc. is a biologics firm focused on orthopedic and sports medicine, committing its efforts to pioneering novel soft tissue repair technologies. The company's primary objective is to elevate the efficacy of sports medicine surgi...